Russell M. Lebovitz, M.D., Ph.D.

Russ worked for 15 + years as a successful senior scientist and research physician in a variety of academic settings before transitioning to a second career focused on financial, operational and executive management of emerging technology companies. In 1995 and 1996 Russ studied management and finance at Rice and Stanford Universities and subsequently worked for a variety of early and intermediate-stage biotech and medical device companies throughout the US . Between 1997 to 2003, Russ managed global projects in operations, marketing and finance for a number of Fortune 100 technology companies including Royal Dutch Shell, Nextel, Cingular Wireless, Johnson & Johnson, Compaq Computer and JPMorganChase, as well as with leading venture capital and investment banking firms. Russ has developed financial models and marketing plans that helped to raise over $100 million for early and intermediate stage pharmaceutical and biomedical device companies. He served as President of C-Sixty, a nanotechnology company based on the intellectually property of Richard Smalley (winner of the Nobel Prize) through the process of technology commercialization and drug development.

Russ completed undergraduate studies at University of Michigan (Phi Beta Kappa), received his M.D. and Ph.D. degrees from Washington University in St. Louis and completed post-graduate biomedical training at the University of Pennsylvania, University of Toronto, Baylor College of Medicine and Washington University. Russ also served on the faculty of Baylor College of Medicine in Houston and The Fox Chase Cancer Center in Philadelphia.

 

Russ Lebovitz